$397.27
0.630.16%
At close: -
$396.74
-0.53-0.13%
After Hours: Dec 20, 4:35 PM EDT
Comments
Loading...
Vertex Pharmaceuticals (VRTX) Forecast
NewsEarningsVertex Pharmaceuticals (VRTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestVertex Pharmaceuticals (NASDAQ:VRTX) Stock Quotes, Forecast and News Summary
Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Vertex Pharmaceuticals (VRTX) stock?
You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.
Who are Vertex Pharmaceuticals (VRTX) competitors?
Other companies in Vertex Pharmaceuticals’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
What is the forecast, or price target, for Vertex Pharmaceuticals (VRTX) stock?
Vertex Pharmaceuticals has a consensus price target of $508.15.
What is the current price for Vertex Pharmaceuticals (VRTX)?
The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $396.7399 last updated December 20, 2024 at 4:35 PM EST.
Does Vertex Pharmaceuticals (VRTX) pay a dividend?
There are no upcoming dividends for Vertex Pharmaceuticals.
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
Vertex Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 3, 2025.
Is Vertex Pharmaceuticals (VRTX) going to split?
There is no upcoming split for Vertex Pharmaceuticals.
What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?
Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.